|Pre- and Post-Intervention Risk Factor Control Rates for Entire Phase Populations, by Study Arm and Priority Level|
|Study Facilities (n = 4)||Control Facilities (n = 4)|
|PHASE Population Size 1||Pre-Intervention % in Control 2||Post-Intervention, % in Control 2||PHASE Population Size 1||Pre-Intervention % in Control 2||Post- Intervention % in Control 2|
|SBP ≥ 140||72,895||83.5||84.0||54,652||81.7||82.4|
|LDL-c ≥ 130||67,099||90.2||91.5||49,355||90.1||91.4|
|A1c ≥ 9%||48,464||90.9||91.0||38,497||90.3||90.7|
1 Members identified in Kaiser Permanente Northern California’s PHASE population from 1 year prior to the intervention to 1 year following the intervention, eligible for the priority by virtue of age and comorbidities, and with at least one risk factor measure in each period.
2 Control assessed based on latest recorded factor value during each period.
Selby et al.
Selby et al. BMC Health Services Research 2012 12:183 doi:10.1186/1472-6963-12-183